THE DRAM VERDICT - June 24th
The numbers that set stage: Gross Margin: guided 81% for Q3→Guidance: $33.5B revenue $19.15 EPS
Why AI has broken DRAM cycle permanently: HBM3E consumes 3-4x the wafer area per bit vs standard DDR5.
substack.com/@handsoff/note…
The memory stock run up is just getting started and this DRAM shortage chart explains exactly why (Save this).
This Deutsche Bank and Gartner forecast is one of the most important charts in tech right now and it tells a very simple story that demand is outrunning supply by a margin that gets worse every single year through the end of the decade.
In 2026, total DRAM requirements are running 210,000 wafer starts per month above available capacity.
By 2027, that shortfall blows out to 507,000 WSPM.
By 2028, it reaches 795,000 WSPM, a 29% demand supply mismatch at the exact moment AI infrastructure spending is still accelerating hard.
The reason the deficit keeps widening even as supply grows is the HBM multiplier effect.
HBM's share of total DRAM wafer capacity rises from 18% in 2025 to 34% by 2028 and one gigabyte of HBM consumes roughly 3 to 4 times the wafer capacity of standard DDR5.
Every wafer diverted to HBM for an Nvidia GPU is a wafer taken directly from standard server DRAM, consumer laptops, and smartphones, creating a shortage that spreads far beyond AI data centers and into the entire global tech supply chain.
Supply cannot respond fast enough and that is the key point the bears keep missing.
New fab capacity requires 2 to 3 years from announcement to volume production meaning every capacity decision being made today does not produce output until 2028 at the earliest.
Goldman forecasts DRAM undersupply persisting through 2027, upgraded Samsung and SK Hynix with higher price targets, and projects HBM pricing rising another 44% in 2027 even after the sharp increases already seen this year.
Samsung can currently only fulfill 70% of DRAM orders, SK Hynix has sold out its entire 2026 and 2027 HBM allocation already, and server DRAM margins at both companies are running above 80%.
Micron is the most direct way to own this trade in the US market.
It is one of three companies on earth that can produce HBM at scale, its full 2026 HBM allocation is sold out, and Deutsche Bank raised its price target by 67% specifically because of this demand-supply model.
The chart shows pricing power does not peak until 2028 meaning we are still in the early innings of this supercycle, and the stocks have significantly more room to run.
Come join Milk Road Pro for our full breakdown, the complete memory supercycle thesis, how to think about Micron, SK Hynix, and Samsung relative to where we are in the cycle, and our entire AI thesis!
Link below!
Peter Lynch on owning cyclical stocks
"At Magellan, I loaded up on cyclical stocks during the 1981-1982 economic slump.
This strategy was one of the keys to Magellan's success...
The best time to get involved with cyclicals is when the economy is at its weakest, earnings are at their lowest, and public sentiment is at its bleakest.
The staff at Standard & Poor's weekly newsletter, The Outlook, once reviewed the eight recessions since World War II to find out what happened to the prices of key cyclical stocks after the stock market hit bottom.
In every instance, the cyclical groups gained 50 percent or better in five months, more than double the advance of the S&P 500."
$285A.T | Kioxia's Investor Day
Kioxia raised its CY25-28 NAND exabyte demand CAGR from 20% to 22%, with #AlInference growing at 86% CAGR. Data centres will account for ~50% of all flash demand by CY28. Supply/ demand remains in deficit through CY27.
substack.com/@handsoff/note…
$ASML | Chips Can’t Wait: ASML’s Q1 2026 Beat Signals AI Is Pulling Forward the Cycle
open.substack.com/pub/handsoff/p…
1. AI demand outpacing supply — FY26 guidance raised to €36–40B:
2. Q1 gross margin of 53.0%
3. China exposure declined to ~19% of system sales (vs. 36% in Q4’25)
$KLAC | KLA Beat Across the Board: Process Control Dominance Intact
open.substack.com/pub/handsoff/p…
1.Results beat on strong Process Control and Services demand
2. WFE outlook upgraded to $140B+ for CY26; 2027 outlook also raised
3. China revenue stable at 24%; manageable near-term risk
4 Followers 260 FollowingNot a trader, I swear. Just obsessed with capturing lowest cost basis on falling knives, which entails lots of buying and selling. NOT INVESTMENT ADVICE.
15 Followers 321 FollowingNot a trader, I swear. Just obsessed with capturing lowest cost basis on falling knives, which entails lots of buying and selling. NOT INVESTMENT ADVICE.
12 Followers 611 FollowingNot a trader, I swear. Just obsessed with capturing lowest cost basis on falling knives, which entails lots of buying and selling. NOT INVESTMENT ADVICE.
25K Followers 915 FollowingYoung self-taught investor and Software dev
| Quality Value Investing
| Writer at Substack
| Entertainment only, no financial advice
5K Followers 4K FollowingDIGICOM Electronics offers Electronics Manufacturing Services including automated assembly for PCB, semiconductor packaging, aerospace, and medical industries.
9K Followers 9K Following#Semiconductor #NanoTech trend spotter. Bio-gnostix -#3D Surgical Models. #Optomist. A learner toward #leadership and all of life. Hunger Fighter
337 Followers 2K FollowingN for Nobody. Drive(n). Fascinated by the markets. Read-Digest-Apply-Fail-Rinse-Repeat. Then One Day ... BOOM! zz PS: not financial advice.
491 Followers 909 FollowingEquity Analyst at @williamoneilco covering technology stocks. Loyola Marymount University MBA alumnus. Tweets/RTs do not constitute investment advice.
47K Followers 5K FollowingAuthor, "RICHER, WISER, HAPPIER: How the World's Greatest Investors Win in Markets & Life" (https://t.co/7842Q0Vv1B). Host of the Richer, Wiser, Happier podcast.
4K Followers 5K FollowingConnects microelectronics professionals to advance the technology & business of electronics design & manufacturing. #SEMICONWest #SEMI_FLEX #SEMI_SMC
139K Followers 1K FollowingSemiAnalysis
Boutique AI Infrastructure Research and Consulting
DMs are open for consulting, quotes, or to talk shop,
Opinions my own
4K Followers 668 FollowingMarketWatch columnist. Cabot. Stock letter: https://t.co/OURT9jAARf. 🚫 consensus. Prior: NYT Business Economist Group MSN Columbia Biz Schl, Hopkins SAIS Italy.
631 Followers 7K FollowingInterested in ESG investing, degrowth, sustainability. Amazed at how much Conservatives love Orwell’s 1984. “One man gathers what another man spills.” ⚡️🌎🌲♻️
449 Followers 437 FollowingCharts and market analysis - technical and fundamental approach - mainly top down. Former HF & PM.
Tweets are personal notes.
25K Followers 8 FollowingIndia's largest Small Finance Bank is on its journey to become a Universal Bank. Never share banking details/PIN/OTP on social media.
46K Followers 2K FollowingCEO & Principal Analyst @creativestrat. Full-stack tech analysis from silicon to markets. Advisor to tech leaders. Technologist at heart. Keeper of Bees.
67K Followers 180 FollowingThe first and only space-based cellular broadband network for mobile phones. Eliminating coverage gaps to enable billions of people globally to stay connected.
876K Followers 175 FollowingI only use X, beware of imposters.
AI/Semi Supply Chain Analyst
Not investment advice, DYODD. Now publishing free research on AI chokepoints.
121K Followers 291 Following40+ years helping financial professionals stay ahead of market trends.
We do not reply to DMs/comments. For support, visit https://t.co/nXEDyR00YV.
75 Followers 50 FollowingSolving combined storage and energy challenges for data centers by removing up to 70% of unnecessary information in semiconductors.
4 Followers 260 FollowingNot a trader, I swear. Just obsessed with capturing lowest cost basis on falling knives, which entails lots of buying and selling. NOT INVESTMENT ADVICE.
20K Followers 651 FollowingFounded in 2000, TrendForce is a global provider of market intelligence on technology industries based in Taipei. Also find us on https://t.co/FHEud9jhQd
20K Followers 189 FollowingNot a trader, I swear. Just obsessed with capturing lowest cost basis on falling knives, which entails lots of buying and selling. NOT INVESTMENT ADVICE.
26.0M Followers 1K FollowingTop and breaking news, pictures and videos from Reuters. For breaking business news, follow @ReutersBiz. Our daily podcast is here: https://t.co/KO0QFy0d3a
5K Followers 192 FollowingBreaking World News | Global Agenda | Geopolitics | Updated every hour
Follow for real-time international updates → @mrglobenews
258 Followers 10 FollowingInstituição bancária especializada em banca privada tendo como principal objetivo o aconselhamento e a proteção do património dos Clientes.
6K Followers 375 FollowingQuality-Growth Investor | I study great investors and share their insights with you | Helping you earn a high return on your Invested Capital
23K Followers 291 FollowingUnofficial Tesla Club India | EV FUD Busters Inc | Building a Community for Future | Every EV Supported | Trying to bring rEVolution here- @NCBirbhan @ArunBhatS
2.1M Followers 624 FollowingOfficial X account for The Kobeissi Letter, an industry leading commentary on the global capital markets. Email us: [email protected]
149K Followers 80 FollowingCEO, and Co-founder Sensibull. India's largest options platform. Free on Zerodha
President, JP Nagar Cartel - Spiritual home of the Indian Bear
134K Followers 999 FollowingGP https://t.co/cvXKvUFfbd. Founder of @carryhq_ (sold to @AngelList). Founded @teachable (sold to @hotmart). Not financial advice, views are personal.
16K Followers 216 FollowingI talk about growth stock investing, fundamental analysis with a long-term mindset. I provide earnings reviews and key news updates.
2K Followers 38 FollowingOptimize, o seu parceiro de confiança.
📌 Sociedade portuguesa e independente
📌 Performances comprovadas
📌 Fundos de Investimento e PPR
8K Followers 0 FollowingUsing AI to summarise companies' earnings. Not advice. AI could make mistakes, double check the output.
Articles with charts - https://t.co/XPvKIyrLjC
1K Followers 382 FollowingMedGenome is a global leader in precision genomic diagnostics, offering 1300+ tests to support early, accurate diagnosis across disease areas.